Are you Dr. Trevarthen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 S Sherman St
Spokane, WA 99202Phone+1 509-228-1000Fax+1 509-252-9300
Summary
- Dr. David Trevarthen, MD is an oncologist in Spokane, Washington.
Publications & Presentations
PubMed
- 15 citationsEfficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma.Panayiotis Panayiotidis, George A Follows, Luigina Mollica, Arnon Nagler, Muhit Ozcan
Blood Advances. 2021-02-09 - 97 citationsLong‐term safety and efficacy of the PI3K‐ inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2‐year follow‐up of the CHRONOS‐1 studyMartin Dreyling, Armando Santoro, Luigina Mollica, Sirpa Leppä, George A Follows
American Journal of Hematology. 2020-04-01 - 62 citationsAnalysis of cell-free DNA from 32,989 advanced cancers reveals novel co-occurring activating RET alterations and oncogenic signaling pathway aberrationsThereasa A. Rich, Karen L. Reckamp, Young Kwang Chae, Robert C. Doebele, Wade T. Iams
Clinical Cancer Research. 2019-01-01